Our findings could potentially be relevant to other chronic lung diseases such as COPD in which VX-770 has been considered as a therapeutic for dysfunctional CFTR (Solomon et al., 2016), and may open new research directions toward understanding the impact of inflammation on biogenesis of other ABC proteins, which are involved in multiple diseases. Here, CFTR is linked to chronic lung disease.